Mixed connective tissue disease historical perspective: Difference between revisions
No edit summary |
|||
(15 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Mixed connective tissue disease}} | |||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{SHH}} | ||
==Overview== | ==Overview== | ||
In 1972, Gordon C.Sharp was the first physician who defined MCTD. It has been the first [[Rheumatology|rheumatic]] disease syndrome that has represented by a [[serologic]] test. In 1976, Alarcon-Segovia proposed criteria for MCTD classifying between all types of [[Connective tissue disease|connective tissue diseases]]. It represents the close association between MCTD and [[Sjögren's syndrome|Sjogren's syndrome]]. | |||
==Historical Perspective== | ==Historical Perspective== | ||
*In 1972, Gordon C.Sharp was the first physician who defined MCTD. | |||
*MCTD has been the first [[Rheumatology|rheumatic]] disease syndrome that has represented by a [[serologic]] test (positive U1RNP).<ref name="pmid24969199">{{cite journal |vauthors=Vij M, Agrawal V, Jain M |title=Scleroderma renal crisis in a case of mixed connective tissue disease |journal=Saudi J Kidney Dis Transpl |volume=25 |issue=4 |pages=844–8 |date=July 2014 |pmid=24969199 |doi= |url=}}</ref><ref name="pmid18439877">{{cite journal |vauthors=Hoffman RW, Maldonado ME |title=Immune pathogenesis of Mixed Connective Tissue Disease: a short analytical review |journal=Clin. Immunol. |volume=128 |issue=1 |pages=8–17 |date=July 2008 |pmid=18439877 |doi=10.1016/j.clim.2008.03.461 |url=}}</ref> | |||
*MCTD | *In 1976, Alarcon-Segovia proposed criteria for MCTD classifying between all types of [[Connective tissue disease|connective tissue diseases]]. It represents the close association between MCTD and [[Sjögren's syndrome|Sjogren's syndrome]]. | ||
*In 1987, Sharp, Alarcon-Segovia and The Research Committee of Japanese Ministry of Health and Welfare for MCTD (JMHW) suggested three groups of criteria for diagnosing MCTD.<ref name="pmid6512789">{{cite journal |vauthors=Alarcón-Segovia D |title=Symptomatic Sjögren's syndrome in mixed connective tissue disease |journal=J. Rheumatol. |volume=11 |issue=5 |pages=582–3 |date=October 1984 |pmid=6512789 |doi= |url=}}</ref> | |||
==References== | ==References== | ||
Line 15: | Line 18: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category: | [[Category:Medicine]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Rheumatology]] |
Latest revision as of 18:35, 3 May 2018
Mixed connective tissue disease Microchapters |
Differentiating Mixed connective tissue disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Mixed connective tissue disease historical perspective On the Web |
American Roentgen Ray Society Images of Mixed connective tissue disease historical perspective |
FDA on Mixed connective tissue disease historical perspective |
Mixed connective tissue disease historical perspective in the news |
Blogs onMixed connective tissue disease historical perspective |
Directions to Hospitals Treating Mixed connective tissue disease |
Risk calculators and risk factors for Mixed connective tissue disease historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shaghayegh Habibi, M.D.[2]
Overview
In 1972, Gordon C.Sharp was the first physician who defined MCTD. It has been the first rheumatic disease syndrome that has represented by a serologic test. In 1976, Alarcon-Segovia proposed criteria for MCTD classifying between all types of connective tissue diseases. It represents the close association between MCTD and Sjogren's syndrome.
Historical Perspective
- In 1972, Gordon C.Sharp was the first physician who defined MCTD.
- MCTD has been the first rheumatic disease syndrome that has represented by a serologic test (positive U1RNP).[1][2]
- In 1976, Alarcon-Segovia proposed criteria for MCTD classifying between all types of connective tissue diseases. It represents the close association between MCTD and Sjogren's syndrome.
- In 1987, Sharp, Alarcon-Segovia and The Research Committee of Japanese Ministry of Health and Welfare for MCTD (JMHW) suggested three groups of criteria for diagnosing MCTD.[3]
References
- ↑ Vij M, Agrawal V, Jain M (July 2014). "Scleroderma renal crisis in a case of mixed connective tissue disease". Saudi J Kidney Dis Transpl. 25 (4): 844–8. PMID 24969199.
- ↑ Hoffman RW, Maldonado ME (July 2008). "Immune pathogenesis of Mixed Connective Tissue Disease: a short analytical review". Clin. Immunol. 128 (1): 8–17. doi:10.1016/j.clim.2008.03.461. PMID 18439877.
- ↑ Alarcón-Segovia D (October 1984). "Symptomatic Sjögren's syndrome in mixed connective tissue disease". J. Rheumatol. 11 (5): 582–3. PMID 6512789.